![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Evaluation of the disposition and mass balance recovery of vebicorvir,
a first-generation hepatitis B core inhibitor, in rats and humans
|
|
|
EASL 2022 June 22-26 London
Katie Zomorodi, Luisa M. Stamm, William Delaney, Michael Shen
Assembly Biosciences, Inc., South San Francisco, CA, USA
![0705221](../images/070522/070522-7/0705221.gif)
![0705222](../images/070522/070522-7/0705222.gif)
![0705223](../images/070522/070522-7/0705223.gif)
![0705224](../images/070522/070522-7/0705224.gif)
![0705225](../images/070522/070522-7/0705225.gif)
![0705226](../images/070522/070522-7/0705226.gif)
![0705227](../images/070522/070522-7/0705227.gif)
![0705228](../images/070522/070522-7/0705228.gif)
![0705229](../images/070522/070522-7/0705229.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|